Landscapes / Companies
AB Science not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 3 in all
Trials
4 active
14 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Phase 3 | Dec 2027Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Amyotrophic Lateral Sclerosis, Alzheimer Disease and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- Isoquercetin
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021